About Smart & Bi

We guide through various steps of access

  • feasibility analyses of reimbursement submission
  • compilation of the reimbursement dossier
  • compilation of the price dossier
  • advice on pre-submission approaches
  • risk sharing and managed entry schemes
  • budget impact assessments (BIA)
  • health technology and relative effectiveness assessment / appraisal of cost-effectiveness
  • description of the disease burden and (unmet) medical need
  • further procedural assistance
  • stakeholder mapping and interaction
  • early dialogue
  • data management / biostatistics / business intelligence


Our areas of expertise extend to:

  • innovative medicinal products
  • orphan drugs
  • biologicals, including biosimilars
  • hospital and retail environment


We provided since our start services for:

Most recent